| Mon, Oct 26, 2009 | | • | Allos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009
Business Wire (Mon, Oct 26)
| | Thu, Oct 22, 2009 | | • | These 5 Underdogs Are No Dogs
at Motley Fool (Thu, Oct 22)
| | Tue, Oct 13, 2009 | | • | Allos raises $93M in stock offer
at bizjournals.com (Tue, Oct 13)
| | • | Allos Therapeutics closes $93 million offering
AP (Tue, Oct 13)
| | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Oct 13)
| | • | Allos Therapeutics Announces Closing of Public Offering
Business Wire (Tue, Oct 13)
| | Mon, Oct 12, 2009 | | • | Dow surges, then sags to modest gain; Teton Energy leads Colorado gainers
at bizjournals.com (Mon, Oct 12)
| | Wed, Oct 7, 2009 | | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Fina
EDGAR Online (Wed, Oct 7)
| | Tue, Oct 6, 2009 | | • | Early Movers: Pump Up the Volume
at TheStreet.com (Tue, Oct 6)
| | Mon, Oct 5, 2009 | | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Mon, Oct 5)
| | Sun, Oct 4, 2009 | | • | [video] Top Biotech Stock Picks
at TheStreet.com (Sun, Oct 4)
| | Fri, Oct 2, 2009 | | • | [video] Biotech Lightning Round
at TheStreet.com (Fri, Oct 2)
| | • | Biotech Mailbag: Cel-Sci, BioElectronics
at TheStreet.com (Fri, Oct 2)
| | Wed, Sep 30, 2009 | | • | Lightning Round OT: Allos Therapeutics, Parker Drilling and More
at CNBC (Wed, Sep 30)
| | • | 5 Stocks Approaching Greatness
at Motley Fool (Wed, Sep 30)
| | • | Biotech Calendar: Key Dates and Events
at TheStreet.com (Wed, Sep 30)
| | Tue, Sep 29, 2009 | | • | [video] Top Biotech Stock Picks
at TheStreet.com (Tue, Sep 29)
| | Fri, Sep 25, 2009 | | • | Stocks End Lower Amid Recovery Worries
at CNBC (Fri, Sep 25)
| | • | Wall St suffers biggest weekly loss since July
at FT.com (Fri, Sep 25)
| | • | Dendreon Makes The List...Again
at CNBC (Fri, Sep 25)
| | • | Stocks Struggle as Home Sales Disappoint
at CNBC (Fri, Sep 25)
| | • | Allos Therapeutics, Inc. Conference Call to Discuss FOLOTYN: First and Only FDA-Approved Therapy for Relapsed or Refractory PTCL scheduled for 9:00 am ET today
CCBN (Fri, Sep 25)
| | • | ALLOS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme
EDGAR Online (Fri, Sep 25)
| | • | Futures Lower as Durables Disappoint
at CNBC (Fri, Sep 25)
| | • | FDA Approves Allos Lymphoma Drug: BioBuzz
at TheStreet.com (Fri, Sep 25)
|
Add ALTH News to My Yahoo!:
 
| |
|
0.24% Nasdaq 
Headlines
